Study on Dynamic Environmental Exposome of ICU and the Establishment of Microbial Transmission Model Between Environment and Host
1 other identifier
observational
180
1 country
1
Brief Summary
HAI (Hospital-acquired infection) is very common in ICU,and lack of understanding of environmental exposure omics and environment-host microbial interactions restricts the prevention and control of HAI. In this project, the investigators try to analyze the spatial and temporal distribution characteristics and evolution of microorganisms and their functions in the ICU environment through metagenome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2022
CompletedFirst Submitted
Initial submission to the registry
May 17, 2023
CompletedFirst Posted
Study publicly available on registry
May 26, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2023
CompletedJune 22, 2023
May 1, 2023
12 months
May 17, 2023
June 20, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Community of microbiome in ICU
the dynamic changes of metagenomic/16s sequencing data
1 year
Study Arms (3)
open ICU
open ICU: open ICU
negative ICU
negative ICU: negative-pressure laminar flow ward
positive ICU
positive ICU: laminar flow ward
Interventions
1. Endotracheal aspiration: from discarded samples after expectoration care 2. BALF (bronchoalveolar lavage fluid): if patients with fiber bronchoscope examination, take the rest of the BALF after examination 3. Oropharyngeal swabs
Eligibility Criteria
Patients with mechanical ventilation, age ≥18 years, anticipated ICU stay for more than 2 days, and with two or more of the following ventilator-associated pneumonia (VAP) risk factors were included in this study.
You may qualify if:
- With mechanical ventilation
- Age ≥18 years
- Anticipated ICU stay for more than 2 days
- With two or more of the following ventilator-associated pneumonia (VAP) risk factors
- VAP risk factors: Age ≥ 60 years old; Patients with chronic lung disease; Long-term bedridden; Unconsciousness; Sputum is not easily coughed up; Antibiotics have been used before mechanical ventilation; Long-term use of H receptor blockers and proton pump inhibitors.
You may not qualify if:
- Patients who have not signed the informed consent
- Pregnant
- Systemic diseases and recent use of related drugs
- History of infectious diseases, such as tuberculosis or PPD positive
- History of hypertension and poor blood pressure control (SBP / DBP \> = 140mmHg)
- With severe mental illness
- Long term use of traditional Chinese medicine, probiotics, gastric mucosal protective agents, proton pump inhibitors, chemotherapy or immunosuppressive drugs, etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Peking University Third Hospitallead
- Zhejiang Universitycollaborator
- Central South Universitycollaborator
Study Sites (1)
Peking University Third Hospital
Beijing, Beijing Municipality, 100191, China
Biospecimen
endotracheal aspiration, bronchoalveolar lavage fluid
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 90 Days
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 17, 2023
First Posted
May 26, 2023
Study Start
August 1, 2022
Primary Completion
July 31, 2023
Study Completion
August 31, 2023
Last Updated
June 22, 2023
Record last verified: 2023-05